
Albertsons Companies (ACI) Stock Forecast & Price Target
Albertsons Companies (ACI) Analyst Ratings
Bulls say
Albertsons Companies has demonstrated steady growth with a net sales revenue increase of 2.08% year-over-year, reaching $81.37 billion, alongside a notable revenue rise in Q2 2026 to $18.92 billion, supported by robust consumer demand across its grocery, pharmacy, and digital channels. The company has shown resilience with a 2.2% increase in comparable sales, driven by non-perishable and pharmacy strengths, bolstered by strong consumer spending trends. Furthermore, significant growth in pharmacy sales, particularly due to higher prescription volumes and the integration of health services, underscores the operational efficiency and market positioning that contribute positively to the financial outlook for Albertsons.
Bears say
The financial analysis reveals a concerning trend for Albertsons Companies, emphasizing a decline in core profitability measures. The gross margin decreased to 27%, primarily attributed to higher digital fulfillment costs and an increased revenue contribution from lower-margin pharmacy and digital segments, contributing to a forecast of adjusted EBITDA margin compression to approximately 4.3%. Additionally, key financial metrics such as Net Operating Profit After Tax (NOPAT) and Economic Profit (EP) exhibited declines of 3.53% and 29.28% year-over-year, respectively, which further underscores the overall weakening financial position of the company.
This aggregate rating is based on analysts' research of Albertsons Companies and is not a guaranteed prediction by Public.com or investment advice.
Albertsons Companies (ACI) Analyst Forecast & Price Prediction
Start investing in Albertsons Companies (ACI)
Order type
Buy in
Order amount
Est. shares
0 shares